Skip to the page

Data / Drug companies / Natco Pharma USA LLC

Natco Pharma USA LLC: 39 products in the FDA NDC directory, labeler code 69339

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Natco Pharma USA LLC (labeler code 69339) lists 39 products in the FDA National Drug Code Directory, covering 18 finished drugs by generic name. By type: 35 prescription drugs, 4 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 2, 2026.

The request: Watch Natco Pharma USA LLC (FDA labeler code 69339): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
69339
Products in commercial distribution
39
Packages
71
Finished drugs by generic name
18
Prescription products
35
Over the counter products
4
Controlled substance products
Schedule IV 11
Flagged as original packager
36 of 36 products that carry the flag
Started marketing in the last 12 months
5
Earliest marketing start
April 25, 2018
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)3384.6%
Over the counter monograph drugs410.3%
Authorized generics (NDA)25.1%

Products by type

TypeProductsShare
Prescription drugs3589.7%
Over the counter drugs410.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet1743.6%
Injection, solution1025.6%
Solution410.3%
Tablet, film coated25.1%
Syrup25.1%
Capsule, gelatin coated25.1%
Suspension12.6%
Liquid12.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Carboplatin69339-367Injection, solutionGeneric drugs (ANDA)July 2, 2026
Carboplatin69339-366Injection, solutionGeneric drugs (ANDA)July 2, 2026
Carboplatin69339-365Injection, solutionGeneric drugs (ANDA)July 2, 2026
Carboplatin69339-364Injection, solutionGeneric drugs (ANDA)July 2, 2026
Desloratadine69339-194Tablet, film coatedGeneric drugs (ANDA)April 1, 2026
Bisoprolol fumarate69339-237TabletGeneric drugs (ANDA)November 25, 2024
Bisoprolol fumarate69339-236TabletGeneric drugs (ANDA)November 25, 2024
Paclitaxel69339-229Injection, solutionGeneric drugs (ANDA)November 7, 2024
Paclitaxel69339-228Injection, solutionGeneric drugs (ANDA)November 7, 2024
Paclitaxel69339-227Injection, solutionGeneric drugs (ANDA)November 7, 2024
Megestrol Acetate69339-160SuspensionGeneric drugs (ANDA)July 31, 2023
Alprazolam69339-202TabletGeneric drugs (ANDA)July 28, 2023
Alprazolam69339-201TabletGeneric drugs (ANDA)July 28, 2023
Alprazolam69339-200TabletGeneric drugs (ANDA)July 28, 2023
Alprazolam69339-199TabletGeneric drugs (ANDA)July 28, 2023
Teriflunomide69339-170TabletGeneric drugs (ANDA)June 17, 2023
Teriflunomide69339-169TabletGeneric drugs (ANDA)June 17, 2023
Gefitinib69339-168Tablet, film coatedGeneric drugs (ANDA)June 5, 2023
Armodafinil69339-180TabletGeneric drugs (ANDA)March 23, 2023
Armodafinil69339-179TabletGeneric drugs (ANDA)March 23, 2023
Armodafinil69339-178TabletGeneric drugs (ANDA)March 23, 2023
Armodafinil69339-177TabletGeneric drugs (ANDA)March 23, 2023
Ondansetron69339-172TabletGeneric drugs (ANDA)October 24, 2022
Ondansetron69339-171TabletGeneric drugs (ANDA)October 24, 2022
Lubiprostone69339-163Capsule, gelatin coatedAuthorized generics (NDA)October 17, 2022

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.